Patrick Mauro Investment Advisor, Inc. Bristol Myers Squibb CO Transaction History

Patrick Mauro Investment Advisor, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $604,394 - $795,697	-15,016 Reduced 55.48%	12,051 $500,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $911,955 - $1.03 Million	19,007 Added 235.82%	27,067 $1.47 Million
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $1.07 Million - $1.28 Million	-22,050 Reduced 73.23%	8,060 $413,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $62,173 - $69,520	1,074 Added 3.7%	30,110 $1.75 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $1.46 Million - $1.62 Million	22,888 Added 372.28%	29,036 $1.86 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $22,209 - $25,191	-338 Reduced 5.21%	6,148 $426,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $105,938 - $125,446	-1,547 Reduced 19.26%	6,486 $466,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,044 - $617,255	8,033 New	8,033 $571,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Patrick Mauro Investment Advisor, Inc., based on Form 13F filings with the SEC.

Stay updated on Patrick Mauro Investment Advisor, Inc. with notifications on news.